Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Yoon, Sook-Yee" or (type any "bookEditor journalEditor issueEditor" and editor="Yoon, Soo...

Add to list
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M. Dunning, James Redman, James Scarth, Inga Plaskocinska, et al.

(2020) Journal of Clinical Oncology. 38(7). p.674-687
Add to list
Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants : results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Valentina Silvestri, Goska Leslie, Daniel R. Barnes, Bjarni A. Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L. Andrulis, Rosa B. Barkardottir, Alicia Barroso, Daniel Barrowdale, et al.

(2020) JAMA ONCOLOGY. 6(8). p.1218-1230
Add to list
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

Vivek L. Patel, Evan L. Busch, Tara M. Friebel, Angel Cronin, Goska Leslie, Lesley McGuffog, Julian Adlard, Simona Agata, Bjarni A. Agnarsson, Munaza Ahmed, et al.

(2020) CANCER RESEARCH. 80(3). p.624-638
Add to list
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Timothy R Rebbeck, Tara M Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Ava Kwong, Edith Olah, Olufunmilayo I. Olopade, Angela R Solano, Soo-Hwang Teo, et al.

(2018) HUMAN MUTATION. 39(5). p.593-620
Add to list
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores

Julie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie, Piera Rizzolo, Anna Sara Navazio, et al.

(2017) JOURNAL OF CLINICAL ONCOLOGY. 35(20). p.2240-2250
Add to list
- Journal Article
- A1
- open access
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, Susan L Neuhausen, Stephen Fox, Beth Y Karlan, Gillian Mitchell, Paul James, Darcy L Thull, Kristin K Zorn, et al.

(2016) BREAST CANCER RESEARCH. 18.
Add to list
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

Alison M Dunning, Kyriaki Michailidou, Karoline B Kuchenbaecker, Deborah Thompson, Juliet D French, Jonathan Beesley, Catherine S Healey, Siddhartha Kar, Karen A Pooley, Elena Lopez-Knowles, et al.

(2016) NATURE GENETICS. 48(4). p.374-386
Add to list
BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

Huong D Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, Lesley McGuffog, Steve Ellis, et al.

(2016) JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 108(2).

Academic Bibliography

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants : results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

Contents

Support

Contact